Algert Global LLC Mustang Bio, Inc. Transaction History

Algert Global LLC

  • $3.72 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$2.58 - $3.36 $167,880 - $218,635
-65,070 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$2.7 - $3.81 $9,801 - $13,830
3,630 Added 5.91%
65,070 $216,000
Q3 2020

Nov 16, 2020
BUY
$3.01 - $3.88 $134,336 - $173,164
44,630 Added 265.5%
61,440 $194,000
Q2 2020

Aug 12, 2020
SELL
$2.33 - $4.6 $17,172 - $33,902
-7,370 Reduced 30.48%
16,810 $53,000
Q1 2020

May 13, 2020
BUY
$1.91 - $4.52 $46,183 - $109,293
24,180 New
24,180 $65,000

Others Institutions Holding MBIO

# of Institutions
2
Shares Held
415K
Call Options Held
0
Put Options Held
0
View Full List

About MUSTANG BIO, INC.

MBIO Quotes by TradingView
  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $24.2M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email